Search clinical trials for: AFFITOPE AD01

Total 78 results

Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Affiris AG

Completed

Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease

Alzheimer's Disease

France, Austria, Croatia, Germany, Czech Republic, Slovakia
Affiris AG

Completed

Safety and Tolerability of AFFITOPE AD03 (MimoVax)

Alzheimer's Disease

Austria
Affiris AG

Completed

Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02

Alzheimer's Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Affiris AG

Terminated

Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006

Alzheimer´s Disease

France, Austria, Croatia, Czech Republic, Germany, Slovakia
Affiris AG
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Completed

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA (AFF009)

Neurodegenerative Diseases | Multiple System Atrophy

France
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease

Parkinson's Disease

Austria
Affiris AG
Medical University of Vienna

Completed

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects (AFF012)

Hypercholesterolemia

Austria
Affiris AG

Completed

Follow-up Study to Assess a Second Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008AA)

Parkinson's Disease

Austria
Affiris AG
Medical University Innsbruck; Forschungszentrum Juelich; PROSENEX AmbulatoriumbetriebsGMBH

Completed

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease (AFF011)

Parkinson Disease | Neurodegenerative Diseases

Austria
Affiris AG

Completed

Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008A)

Parkinson's Disease

Austria
Rocket Pharmaceuticals Inc.

Active, not recruiting

Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B

Danon Disease

United States
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RD01 (Pegerythropoietin) in Healthy Chinese Volunteers

Healthy

China
Affiris AG
University Hospital Tuebingen

Withdrawn

Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients

Parkinson's Disease

Germany
AnaCardio AB

Recruiting

Phase Ib/IIa Trial With AC01 in Patients With HFrEF (GOAL-HF1)

Heart Failure With Reduced Ejection Fraction

United Kingdom, Sweden, Netherlands, Italy
Rocket Pharmaceuticals Inc.

Recruiting

A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

Danon Disease

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients

Diabetes After Total Pancreatectomy

China
Rocket Pharmaceuticals Inc.

Recruiting

A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

United States
National Taiwan University Hospital
Taipei Veterans General Hospital, Taiwan; Development Center for Biotechnology... and other collaborators

Unknown

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

Dementia, Alzheimer Type

Taiwan
Queensland Institute of Medical Research
National Health and Medical Research Council, Australia; Australian Department... and other collaborators

Completed

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas (EPL)

Lymphoma

Australia
Biotronik SE & Co. KG

Active, not recruiting

SD01 Registry (SD01 ICD Lead) (SD01 Registry)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia

Germany
Biotronik SE & Co. KG

Active, not recruiting

SD01 Master Study (Safety and Efficacy Study)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia

Germany, Hungary, France, Czechia, Latvia
Attralus, Inc.

Active, not recruiting

A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis (AT01-001)

Amyloidosis

United States
BlueRock Therapeutics
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease

Advanced Parkinson's Disease

United States, Canada
Neuraly, Inc.

Completed

A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

NAFLD | Overweight and Obesity | Type2 Diabetes

United States, Puerto Rico
USANA Health Sciences
Roseman University of Health Sciences

Completed

The Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste

Oral Health

United States
Sun Yat-sen University

Recruiting

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Solid Tumor | Intestinal Flora | Immune Checkpoint Inhibitor

China
PsiOxus Therapeutics Ltd

Completed

Mechanism of Action Trial of ColoAd1 (MOA)

Resectable Colon Cancer | Resectable Non-small Cell Lung Cancer | Resectable Bladder Cancer | Resectable Renal Cell Carcinoma

Spain
Maastricht University Medical Center

Completed

The Effect of PD01 on Cardiovascular Health and Microbial Environment

Obesity | Overweight

Netherlands
HK inno.N Corporation

Not yet recruiting

A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers

Healthy

Korea, Republic of
Neuraly, Inc.

Not yet recruiting

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

NAFLD | NASH

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
First Affiliated Hospital of Wannan Medical College

Recruiting

The Safety and Effectiveness of NV-A01 in Glioma Patients

Advanced Glioblastoma Patients

China
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
University of Sao Paulo General Hospital

Not yet recruiting

Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals

HIV Vaccine

Brazil
Naryx Pharma

Completed

Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis

Chronic Sinusitis

United States
Hangzhou Converd Co., Ltd.
The Second Hospital of Jia Xing

Unknown

Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer

Gastrointestinal Cancer
GlaxoSmithKline

Completed

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

Influenza, Human

United States, Belgium
HK inno.N Corporation

Completed

Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

Healthy

Korea, Republic of
Hangzhou Converd Co., Ltd.
The Second People's Hospital of Yibin

Unknown

Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid Tumors

Advanced Solid Tumors
Taipei Veterans General Hospital, Taiwan

Unknown

The Efficacy of Traditional Chinese Herbal Medicine for Alzheimer's Disease

Alzheimer Disease
Michigan State University
Boston University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Recruiting

RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi (RTSS/PBO)

Malaria, Malaria Vaccine, Insecticide-treated Bednets

Malawi
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd

Unknown

A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Patient of Anemia in Chronic Renal Failure With Hemodialysis

China
London School of Hygiene and Tropical Medicine
Malaria Research and Training Center, Bamako, Mali; Institut de Recherche en...

Completed

Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) (RTSS-SMC)

Children, Only | Malaria,Falciparum

Burkina Faso, Mali
Sormland County Council, Sweden
Karolinska Institutet

Completed

TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs

Rheumatoid Arthritis | Immunosuppression | Exposed to TBE-virus

Finland, Sweden
Dhp Korea Co., Ltd.

Completed

Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome

Dry Eye Syndromes | Keratoconjunctivitis Sicca

Korea, Republic of
Unilever R&D
Pesquisa e Ensino em Saúde, Porto Allegre, Brazil

Completed

A Pilot Study to Substantiate the Use of the Jay Sensitivity Sensor Probe

Dentine Sensitivity
University of Oxford
National Institute for Health Research, United Kingdom; The PATH Malaria Vaccine...

Completed

A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

Plasmodium Falciparum Malaria

United Kingdom
London School of Hygiene and Tropical Medicine
Malaria Research and Training Center, Bamako, Mali; Institut de Recherche en...

Completed

Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study (RTSS-SMC)

Child, Only | Malaria,Falciparum

Mali, Burkina Faso

Search clinical trials for: AFFITOPE AD01

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations